The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...
Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
Out of the 386 regencies and mayoralties targeted by the Health Ministry, fewer than half are estimated to have public health ...
The Kenya Times on MSN
List of accredited DNA clinics in Kenya and their charges
DNA testing charges in Kenya vary primarily based on whether you are seeking a government service or a private facility.
Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...
IPOs don’t always get the attention they deserve, yet they play a vital role in renewing the stock market. They bring new ...
News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
In this interview, Dr. Gary Pestano and Dr. Prithwish Pal discuss the advantages ddPCR offers in molecular residual disease ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
Typhoid fever is a serious infection caused by the bacterium Salmonella enterica serotype Typhi (S. Typhi). Enteric fever ...
The Asian longhorn tick is native to Japan, China, Korea, and parts of Russia. Australia and New Zealand imported the tick a ...
Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback